(0.75%) 5 166.38 points
(0.38%) 38 823 points
(0.85%) 16 294 points
(0.14%) $78.22
(2.71%) $2.20
(1.14%) $2 334.90
(3.55%) $27.64
(-0.04%) $964.95
(-0.06%) $0.928
(-0.45%) $10.82
(-0.16%) $0.796
(-0.11%) $91.35
0.21% $ 19.00
Live Chart Being Loaded With Signals
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada...
Stats | |
---|---|
Volumen de hoy | 3.91M |
Volumen promedio | 2.05M |
Capitalización de mercado | 794.69M |
EPS | $0 ( 2024-04-25 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-31 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -17.43 |
ATR14 | $0.410 (2.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-08 | Akkaraju Srinivas | Sell | 640 688 | Common Stock |
2023-11-08 | Akkaraju Srinivas | Sell | 8 111 | Common Stock |
2023-11-08 | Akkaraju Srinivas | Sell | 12 089 | Option to Purchase Common Stock |
2023-11-08 | Akkaraju Srinivas | Sell | 12 790 | Option to Purchase Common Stock |
2023-11-08 | Akkaraju Srinivas | Sell | 12 547 | Option to Purchase Common Stock |
INSIDER POWER |
---|
-100.00 |
Last 100 transactions |
Buy: 0 | Sell: 1 646 020 |
Volumen Correlación
Intercept Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
ADMS | 0.992 |
PATI | 0.988 |
ZGNX | 0.963 |
RETA | 0.958 |
RESN | 0.956 |
TRMR | 0.95 |
DXPE | 0.948 |
MNMD | 0.946 |
SG | 0.945 |
VITL | 0.943 |
10 Correlaciones Más Negativas | |
---|---|
CPSH | -0.949 |
PHCF | -0.943 |
CDAK | -0.942 |
UONE | -0.942 |
AZYO | -0.942 |
TTEC | -0.941 |
DTEA | -0.935 |
UONEK | -0.932 |
JRJC | -0.931 |
OFS | -0.93 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Intercept Pharmaceuticals Correlación - Moneda/Commodity
Intercept Pharmaceuticals Finanzas
Annual | 2022 |
Ingresos: | $285.71M |
Beneficio Bruto: | $284.73M (99.66 %) |
EPS: | $3.40 |
FY | 2022 |
Ingresos: | $285.71M |
Beneficio Bruto: | $284.73M (99.66 %) |
EPS: | $3.40 |
FY | 2021 |
Ingresos: | $363.47M |
Beneficio Bruto: | $360.37M (99.15 %) |
EPS: | $-2.88 |
FY | 2020 |
Ingresos: | $312.69M |
Beneficio Bruto: | $307.37M (98.30 %) |
EPS: | $-8.34 |
Financial Reports:
No articles found.
Intercept Pharmaceuticals
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico